Related Experiment Video
Updated: Jul 5, 2026
09:44
Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
Published on: November 27, 2019
Hepatic diseases in horses.
Journal of Animal Physiology and Animal Nutrition
|May 15, 2008
Summary
This review updates knowledge on liver diseases, focusing on equine hyperlipaemia. Nutritional management is key for treating liver conditions and equine hyperlipaemia, improving outcomes.
Area of Science:
- Veterinary Medicine
- Equine Health
- Hepatology
Background:
- Liver disease encompasses various conditions affecting liver function, ranging from temporary impairment to failure.
- Equine hyperlipaemia is a serious lipid metabolism disorder in horses with high mortality rates.
Purpose of the Study:
- To provide an updated review of hepatobiliary diseases, with a specific focus on equine hyperlipaemia.
- To detail the aetiology, clinical signs, diagnosis, and nutritional management of these conditions.
Main Methods:
- Review of existing literature on equine hepatobiliary diseases and hyperlipaemia.
- Analysis of diagnostic approaches, including serum activity assessment and hepatic biopsy.
- Evaluation of nutritional management strategies for liver conditions and equine hyperlipaemia.
Main Results:
- Diagnosis of hepatic disease often relies on serum enzyme levels, with biopsy as the gold standard.
- Nutritional management for liver disease involves specific dietary adjustments based on protein and carbohydrate content.
- Equine hyperlipaemia is characterized by elevated plasma triglycerides and fat deposition, requiring nutritional support for positive energy balance and metabolic correction.
Conclusions:
- Effective nutritional management is crucial for managing equine liver diseases and hyperlipaemia.
- Addressing lipid metabolism disorders, dehydration, and acidosis is vital for improving outcomes in horses with hyperlipaemia.
Related Concept Videos
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
01:26Diseases of the Liver and Gallbladder
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
01:29Hepatic Encephalopathy
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
01:14Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...